Dermata Therapeutics Inc (NASDAQ: DRMA) shares are trading lower after the company announced topline results from its DMT310 Phase 2 trial, which did not meet primary endpoints.
What Else?
Gainers
Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.
Dermata Therapeutics (NASDAQ:DRMA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Gainers
Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.